Literature DB >> 1539328

Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.

S Friman1, H Persson, T Scherstén, J Svanvik, I Karlberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1539328

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Ursodeoxycholic acid in the treatment of liver diseases.

Authors:  S Saksena; R K Tandon
Journal:  Postgrad Med J       Date:  1997-02       Impact factor: 2.401

2.  Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; C Sama; L Barbara
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

3.  Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat.

Authors:  P E Queneau; P Bertault-Peres; M Guitaoui; E Mesdjian; A Durand; J C Montet
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

4.  Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.

Authors:  Y Nishigaki; H Ohnishi; H Moriwaki; Y Muto
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.